Long noncoding and circular RNAs in lung cancer: advances and perspectives

被引:80
作者
Xie, Weijia [1 ]
Yuan, Shuai [1 ]
Sun, Zhifu [2 ]
Li, Yafei [1 ]
机构
[1] Third Mil Med Univ, Coll Prevent Med, Dept Epidemiol, Chongqing, Peoples R China
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
基金
中国国家自然科学基金;
关键词
biomarkers; circular RNA; long noncoding RNA; lung cancer; oncogenic lncRNA; tumor suppressive lncRNA; CELL-PROLIFERATION; POOR-PROGNOSIS; DOWN-REGULATION; H19; GENE; PROMOTES METASTASIS; TUG1; EXPRESSION; APOPTOSIS; MALAT-1; ADENOCARCINOMA;
D O I
10.2217/epi-2016-0036
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Better understanding and management of lung cancer are needed. Although much has been learned from known protein coding genes, long noncoding RNAs (lncRNAs), a relatively new and fast evolving large family of transcripts, have recently generated much attention for new discoveries. LncRNAs play critical regulatory functions and are emerging as new players in tumorigenesis and phenotypic determinators of lung cancer. In this review, we highlight the latest development of lncRNAs, including circular RNAs in lung cancer. We start with well-characterized lncRNAs and circular RNAs as an oncogene or tumor suppressor and then extend our discussion on the impact of SNPs in lncRNA on its functions and lung cancer risk and the clinical applications of lncRNAs as biomarkers and therapeutic targets.
引用
收藏
页码:1275 / 1287
页数:13
相关论文
共 93 条
[1]
[Anonymous], TUMOUR BIOL
[2]
Ariel I, 2000, AM J MED GENET, V91, P46, DOI 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO
[3]
2-I
[4]
Possible physiological role of H19 RNA [J].
Ayesh, S ;
Matouk, I ;
Schneider, T ;
Ohana, P ;
Laster, M ;
Al-Sharef, W ;
de-Groot, N ;
Hochberg, A .
MOLECULAR CARCINOGENESIS, 2002, 35 (02) :63-74
[5]
MicroRNA expression differentiates between primary lung tumors and metastases to the lung [J].
Barshack, Iris ;
Lithwick-Yanai, Gila ;
Afek, Arnon ;
Rosenblatt, Kinneret ;
Tabibian-Keissar, Hila ;
Zepeniuk, Merav ;
Cohen, Lahav ;
Dan, Harel ;
Zion, Orit ;
Strenov, Yulia ;
Polak-Charcon, Sylvie ;
Perelman, Marina .
PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (08) :578-584
[6]
Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets [J].
Chen, Jing ;
Wang, Rui ;
Zhang, Kai ;
Chen, Long-Bang .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (12) :2425-2436
[7]
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis [J].
Cheng, AM ;
Byrom, MW ;
Shelton, J ;
Ford, LP .
NUCLEIC ACIDS RESEARCH, 2005, 33 (04) :1290-1297
[8]
Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer [J].
Cheng, Ningning ;
Cai, Weijing ;
Ren, Shengxiang ;
Li, Xuefei ;
Wang, Qi ;
Pan, Hui ;
Zhao, Mingchuan ;
Li, Jiayu ;
Zhang, Yishi ;
Zhao, Chao ;
Chen, Xiaoxia ;
Fei, Ke ;
Zhou, Caicun ;
Hirsch, Fred R. .
ONCOTARGET, 2015, 6 (27) :23582-23593
[9]
EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF [J].
Chou, Yu-Ting ;
Lin, Hua-Heng ;
Lien, Yung-Chang ;
Wang, Yuan-Hung ;
Hong, Chun-Fu ;
Kao, Yu-Rung ;
Lin, Sheng-Chieh ;
Chang, Ying-Che ;
Lin, Shu-Yu ;
Chen, Shu-Jen ;
Chen, Hua-Chien ;
Yeh, Shauh-Der ;
Wu, Cheng-Wen .
CANCER RESEARCH, 2010, 70 (21) :8822-8831
[10]
Del Vescovo V, 2014, WORLD J CLIN ONCOL, V5, P604, DOI 10.5306/wjco.v5.i4.604